These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7161788)

  • 21. [Pyrithioxin and rheumatoid polyarthritis].
    Crouzet J; Beraneck L
    Rev Rhum Mal Osteoartic; 1986 Jan; 53(1):45-8. PubMed ID: 3704512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Sulfhydryl-based treatment of rheumatoid arthritis (penicillamine, pyrithioxin, thiopronine)].
    Camus JP; Prier A; Cassou B; Bergevin H
    Rev Prat; 1980 Apr; 30(23):1517-8, 1521-3. PubMed ID: 7384712
    [No Abstract]   [Full Text] [Related]  

  • 23. [Pyrithioxin in the treatment of patients with rheumatoid arthritis (comparative study with D-penicillamine)].
    Tosković B
    Reumatizam; 1983; 30(3):60-8. PubMed ID: 6351211
    [No Abstract]   [Full Text] [Related]  

  • 24. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial.
    Choy EH; Isenberg DA; Garrood T; Farrow S; Ioannou Y; Bird H; Cheung N; Williams B; Hazleman B; Price R; Yoshizaki K; Nishimoto N; Kishimoto T; Panayi GS
    Arthritis Rheum; 2002 Dec; 46(12):3143-50. PubMed ID: 12483717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and efficacy of T-614 in the treatment of patients with active rheumatoid arthritis: a double blind, randomized, placebo-controlled and multicenter trial.
    Lü LJ; Teng JL; Bao CD; Han XH; Sun LY; Xu JH; Li XF; Wu HX
    Chin Med J (Engl); 2008 Apr; 121(7):615-9. PubMed ID: 18466681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Acute polymyositis complicating rheumatoid arthritis treated with pyrithioxin].
    Trèves R; Tabaraud F; Arnaud M; Jacob P; Hugon J; Lubeau M; Burki F; Desproges-Gotteron R
    Rev Rhum Mal Osteoartic; 1984 May; 51(5):283-5. PubMed ID: 6740192
    [No Abstract]   [Full Text] [Related]  

  • 28. [Squamous eruption of the lichen planus histological type during treatment with pyritinol].
    Méraud JP; géniaux M; Tamisier JM; Delaunay MM; Texier L
    Ann Dermatol Venereol; 1980 Jun; 107(6):561-4. PubMed ID: 7425461
    [No Abstract]   [Full Text] [Related]  

  • 29. [Rheumatoid arthritis. Therapeutic efficacy of methotrexate and its hepatotoxic effects].
    Carvallo A; Wolff C; Armas R; Villanueva P; Donoso G; Náquira N; Lobo G; Rojas C; Domic H
    Rev Med Chil; 1993 Jul; 121(7):777-84. PubMed ID: 8296082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [3 cases of lichen induced by pyritinol].
    Duterque M; Crouzet J; Civatte J
    Ann Dermatol Venereol; 1983; 110(9):707-8. PubMed ID: 6660771
    [No Abstract]   [Full Text] [Related]  

  • 31. A randomized, open-label, comparative, 6-month trial of oral ultra-low doses of antibodies to tumor necrosis factor-alpha and diclofenac in rheumatoid arthritis.
    Dugina JL; Petrov VI; Babayeva AR; Martyushev-Poklad AV; Tcherevkova EV; Epstein OI; Sergeeva SA
    Int J Tissue React; 2005; 27(1):15-21. PubMed ID: 15847101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous human recombinant tumor necrosis factor receptor p55-Fc IgG1 fusion protein Ro 45-2081 (lenercept): a double blind, placebo controlled dose-finding study in rheumatoid arthritis.
    Rau R; Sander O; van Riel P; van de Putte L; Hasler F; Zaug M; Kneer J; van der Auwera P; Stevens RM;
    J Rheumatol; 2003 Apr; 30(4):680-90. PubMed ID: 12672184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Open label study to assess infliximab safety and timing of onset of clinical benefit among patients with rheumatoid arthritis.
    Shergy WJ; Isern RA; Cooley DA; Harshbarger JL; Huffstutter JE; Hughes GM; Spencer-Smith EA; Goldman AL; Roth SH; Toder JS; Warner D; Quinn A; Keenan GF; Schaible TF;
    J Rheumatol; 2002 Apr; 29(4):667-77. PubMed ID: 11950005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NTP Toxicology and Carcinogenesis Studies of Turmeric Oleoresin (CAS No. 8024-37-1) (Major Component 79%-85% Curcumin, CAS No. 458-37-7) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Aug; 427():1-275. PubMed ID: 12616304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Myasthenia induced successively by pyritinol, then by captopril, in rheumatoid polyarthritis].
    Kirjner M; Koeger AC; Camus JP
    Therapie; 1987; 42(2):250. PubMed ID: 3303433
    [No Abstract]   [Full Text] [Related]  

  • 37. Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial.
    Bao C; Chen S; Gu Y; Lao Z; Ni L; Yu Q; Xu J; Li X; Liu J; Sun L; He P; Ma J; Xu S; Ding C
    Chin Med J (Engl); 2003 Aug; 116(8):1228-34. PubMed ID: 12935395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of rheumatoid polyarthritis with methotrexate in Dakar: efficacy, tolerance and cost].
    Ka MM; Diallo S; Ka EF; Diop BM; Pouye A; Mbengue M; Leye A; Diouf B; Diop TM
    Sante; 2000; 10(1):65-8. PubMed ID: 10827366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Successful treatment of rheumatoid arthritis with pyrithioxin (Enerbol, Polfa)].
    Brühl W; Cygler B
    Reumatologia; 1979; 17(3):337-8. PubMed ID: 515579
    [No Abstract]   [Full Text] [Related]  

  • 40. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial.
    Lambert CM; Sandhu S; Lochhead A; Hurst NP; McRorie E; Dhillon V
    Arthritis Rheum; 2004 Feb; 50(2):364-71. PubMed ID: 14872477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.